AN2 Therapeutics, Inc. Gains 84.21%

Mon, Mar 09, 2026 at 07:26 PM

AN2 Therapeutics, Inc. (ANTX:NASDAQ) soared at $5.25, a gain of 84.2%. On Mon, Mar 09, 2026, ANTX:NASDAQ touched a New 2-Week High of $5.25. The stock appeared on our News Catalysts scanner on Mon, Mar 09, 2026 at 08:16 AM in the 'PRIVATE PLACEMENT' category. From Mon, Feb 23, 2026, the stock recorded 60.00% Up Days and 63.64% Green Days

The stock spiked on Mon, Mar 09, 2026 at $6.91 with a volume of 57M+.

About AN2 Therapeutics, Inc. (ANTX:NASDAQ)

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs.

Top 10 Gainers:

Garden Stage Limited (GSIW:NASDAQ), 248.11%
Autozi Internet Technology (Global) Ltd. (AZI:NASDAQ), 146.4%
AN2 Therapeutics, Inc. (ANTX:NASDAQ), 84.21%
Davis Commodities Limited (DTCK:NASDAQ), 74.13%
POMDOCTOR LIMITED (POM:NASDAQ), 74.07%
Xenon Pharmaceuticals Inc. (XENE:NASDAQ), 49.64%
CAMP4 THERAPEUTICS CORPORATION (CAMP:NASDAQ), 49.4%
XCF Global Inc. (SAFX:NASDAQ), 46.2%
Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 45.9%
Hims & Hers Health, Inc. (HIMS:NYSE), 40.79%